Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival

Autor: Putao Cen, Kok Hoe Chan, Steven Canfield, Tung Shu, Neha Maithel, Varaha Tammisetti

Publikováno v: Journal of Clinical Oncology. 41:529-529

529 Background: For metastatic or unresectable invasive urothelial cancer (UC), standard first-line platinum-based chemotherapy achieved progression-free survival (PFS) of 4–7 months. Complete response (CR) rate is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bcf26aafb2efb37863c8f05977c3769
https://doi.org/10.1200/jco.2023.41.6_suppl.529

Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus

Autor: Wei Phin Tan, Ardeshir R. Rastinehad, Laurence Klotz, Peter R. Carroll, Mark Emberton, John F. Feller, Arvin K. George, Inderbir S. Gill, Rajan T. Gupta, Aaron E. Katz, Amir H. Lebastchi, Leonard S. Marks, Giancarlo Marra, Peter A. Pinto, Daniel Y. Song, Abhinav Sidana, John F. Ward, Rafael Sanchez-Salas, Jean de la Rosette, Thomas J Polascik, Aaron Katz, Alireza Aminsharifi, Amir Lebastchi, Andre Abreu, Arnauld Villers, Ariel Schulman, Ardeshir Rastinehad, Arvin George, Aytekin Oto, Baris Turkbey, Bernard Malavaud, Berrend Muller, Caroline Moore, Daniel Eberli, Daniel Margolis, Daniel Song, Derek Lomas, Hazem Orabi, Herbert Lepor, Hui Meng Tan, Ivan Jambor, Jeremy Grummet, John Feller, John Ward, Jonathan Colemen, Justin Gregg, Kae Jack Tay, Leonard Marks, Leslie Deane, M. Pilar Laguna, Masaki Kimura, Matvey Tsivian, Michael Gorin, Minhaj Siddiqui, Osamu Ukimura, Paolo Gontero, Peter Carroll, Peter Pinto, Pierre Mozer, Rajan T Gupta, Ro Arcot, Samir Taneja, Sangeet Ghai, Sebastian Crouzet, Sherif Mehralivand, Steven Joniau, Sunao Shoji, Takumi Shiraishi, Thomas Polascik, Toshitaka Shin, Uri Lindnet, Varaha Tammisetti, Willemien van den Bos, Yoh Matsuoka

Publikováno v: Urol Oncol
Urologic oncology, vol 39, iss 11

Background: With the advancement of imaging technology, focal therapy (FT) has been gaining acceptance for the treatment of select patients with localized prostate cancer (CaP). We aim to provide details of a formal physician consensus on the utiliza

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a988e657381323699769417ac8f4aa
http://hdl.handle.net/2318/1829065